ONCY News and Press, Oncolytics Biotech Inc. From 11/10/22

Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer Cohort Canada NewsWire One complete response (CR) and eight partial responses (PR) a...

Penny Stocks To Buy According To 5 Wall Street Analysts Are analysts the ultimate factor in deciding the best penny stocks to buy? In my opinion, they are not, and if you are using analyst ratings in your research, it’s sometimes best to take them with a grain of salt. But ar...

Oncolytics Biotech, Inc. (ONCY) Q3 2022 Earnings Conference Call November 7, 2022, 8:30 am ET Company Participants Jon Patton - Director, IR & Communication Matt Coffey - CEO Tom Heineman - CMO Andrew de Guttadauro - Global Head, Business Development ...

Palm Beach, FL – November 7, 2022 – FinancialNewsMedia.com News Commentary – While there is no cure for pancreatic cancer in the pancreatic cancer treatment market, new treatment options abound, and research is constantly advancing. Pancreatic cancer is 12 ...

Oncolytics Biotech press release ( NASDAQ: ONCY ): Q3 GAAP EPS of -C$0.08 in-line. As of September 30, 2022, the company reported $32.4M in cash and cash equivalents, provides projected runway through key milestones to the end of 2023. For further details see: ...

Oncolytics Biotech® Reports Third Quarter 2022 Financial Results and Recent Operational Highlights Canada NewsWire Clinical interim data reported earlier today from GOBLET trial's pancreatic cancer cohort show an objective response rate (ORR) nearly triple the ave...

Oncolytics Biotech ( NASDAQ: ONCY ) is scheduled to announce Q3 earnings results on Monday, November 7th, before market open. The consensus EPS Estimate is -$0.08 (+11.1% Y/Y) and the consensus Revenue Estimate is $0M Over the last 3 months, EPS estimates have seen 1 ...

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights Canada NewsWire Conference call and webcast to take place on Monday, November 7, 2022 , at 8:30 a.m. ET SAN DIEGO, Calif. a...

Palm Beach, FL – October 5, 2022 – FinancialNewsMedia.com News Commentary – Advanced pancreatic ductal adenocarcinoma (PDAC) remains a significant cause of mortality accounting for up to 4% of all cancer-related deaths worldwide. Of concern, despite treatmen...

Oncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors PR Newswire Mr. Rigby is the Group Chief Executive Officer of Revolo Biotherapeutics and has three decades of experience in the pharmaceutical and biotechnology industries SAN DIEGO ...